Stifel Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-11,264
| Closed | -$125K | – | 3432 |
|
2023
Q2 | $125K | Buy |
+11,264
| New | +$125K | ﹤0.01% | 3137 |
|
2022
Q3 | – | Sell |
-14,691
| Closed | -$203K | – | 3409 |
|
2022
Q2 | $203K | Buy |
14,691
+3,344
| +29% | +$46.2K | ﹤0.01% | 2991 |
|
2022
Q1 | $185K | Buy |
+11,347
| New | +$185K | ﹤0.01% | 3150 |
|
2021
Q1 | – | Sell |
-17,104
| Closed | -$422K | – | 3311 |
|
2020
Q4 | $422K | Buy |
17,104
+10,155
| +146% | +$251K | ﹤0.01% | 2426 |
|
2020
Q3 | $288K | Sell |
6,949
-577
| -8% | -$23.9K | ﹤0.01% | 2431 |
|
2020
Q2 | $361K | Buy |
+7,526
| New | +$361K | ﹤0.01% | 2232 |
|
2020
Q1 | – | Sell |
-2,698
| Closed | -$333K | – | 3138 |
|
2019
Q4 | $333K | Sell |
2,698
-2,144
| -44% | -$265K | ﹤0.01% | 2486 |
|
2019
Q3 | $322K | Buy |
+4,842
| New | +$322K | ﹤0.01% | 2408 |
|
2019
Q2 | – | Sell |
-2,329
| Closed | -$258K | – | 3074 |
|
2019
Q1 | $258K | Buy |
2,329
+61
| +3% | +$6.76K | ﹤0.01% | 2453 |
|
2018
Q4 | $228K | Buy |
+2,268
| New | +$228K | ﹤0.01% | 2392 |
|
2015
Q3 | – | Sell |
-1,193
| Closed | -$288K | – | 2396 |
|
2015
Q2 | $288K | Sell |
1,193
-35
| -3% | -$8.45K | ﹤0.01% | 1985 |
|
2015
Q1 | $347K | Sell |
1,228
-190
| -13% | -$53.7K | ﹤0.01% | 1820 |
|
2014
Q4 | $221K | Buy |
+1,418
| New | +$221K | ﹤0.01% | 2024 |
|